Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENLIGHTEN: ARV Hair Imaging for Adherence
NCT03218592Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc, dolutegravir, emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of North Carolina at Chapel Hill. Started Jun 2017; status: completed.
02
Drugs
maravirocdolutegraviremtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03218592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218592.